NCT07463521
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
- Locations
-
- Mg0038 10106 Amherst, New York, United States
- Mg0038 10103 Columbus, Ohio, United States
Clinical trial condition
Ocular Myasthenia Gravis
Explore clinical trials studying Ocular Myasthenia Gravis. Study availability and eligibility vary by location and protocol.
6 public trials
3 recruiting studies
Ocular Myasthenia Gravis trial results
NCT04182984
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
- Locations
-
- Tangdu Hospotal Xi'an, Shaanxi, China
NCT06342544
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
- Locations
-
- Centre Hospitalier Universitaire De Bordeaux Bordeaux, France
- Hôpital Raymond Pointcarre Garches, France
- Centre Hospitalier Universitaire De Lille Lille, France
- Hospices Civils De Lyon Lyon, France
Not Yet Recruiting
A Study to Evaluate The Long-Term Safety And Efficacy of Rozanolixizumab in Adult Participants With Ocular Myasthenia Gravis
NCT07465289
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
- Locations
-
Not specified
Completed
Efficacy of Apraclonidine Eye Drops in the Treatment of Ptosis Secondary to Myasthenia Gravis
NCT05045248
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
- Locations
-
- American University of Beirut Medical Center Beirut, Lebanon
Completed
Ocular Mysathenia Gravis Generalization
NCT04667650
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
- Locations
-
- Antoine GUEGUEN Paris, France